Cargando…

Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review

BACKGROUND: High recurrence rate after curative treatment is the major problem for hepatocellular carcinoma (HCC). Cytokine-induced killer cells (CIKs) therapy was extensively studied among HCC patients. However, the value of CIKs therapy was controversial. A meta-analysis was performed to investiga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Xiu-Rong, Li, Xing, Lin, Jin-Xiang, Wang, Tian-Tian, Dong, Min, Chen, Zhan-Hong, Jia, Chang-Chang, Hong, Ying-Fen, Lin, Qu, Wu, Xiang-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458210/ https://www.ncbi.nlm.nih.gov/pubmed/28412743 http://dx.doi.org/10.18632/oncotarget.15454

Ejemplares similares

Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection
por: Chen, Jian-Lin, et al.
Publicado: (2016)

Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine-induced killer cells in 294 patients
por: Zhang, Yuhan, et al.
Publicado: (2019)

A Nomogram for Predicting the Benefit of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Hepatocellular Carcinoma
por: Pan, Qiu-Zhong, et al.
Publicado: (2015)

Cost-Effectiveness of Adjuvant Immunotherapy With Cytokine-Induced Killer Cell for Hepatocellular Carcinoma Based on a Randomized Controlled Trial and Real-World Data
por: Cho, Jeong-Yeon, et al.
Publicado: (2021)

Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma
por: Hong, Ying-Fen, et al.
Publicado: (2017)

Immunophenotype and antitumor activity of cytokine-induced killer cells from patients with hepatocellular carcinoma
por: Yang, Chan-Keng, et al.
Publicado: (2023)

Recognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognition
por: Rong, Xiao-Xiang, et al.
Publicado: (2015)

Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data
por: Yoon, Jun Sik, et al.
Publicado: (2019)

Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer
por: Yang, Xinyi, et al.
Publicado: (2022)

Validation and ranking of seven staging systems of hepatocellular carcinoma
por: Chen, Zhan-Hong, et al.
Publicado: (2017)

Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up
por: Lee, Jeong-Hoon, et al.
Publicado: (2018)

Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis
por: Yu, Ruili, et al.
Publicado: (2017)

Efficacy of Enhanced Cytokine-Induced Killer Cells as an Adjuvant Immunotherapy for Renal Cell Carcinoma: Preclinical and Clinical Studies
por: Yang, Yang, et al.
Publicado: (2021)

Cytokine-Based Generation of CD49a(+)Eomes(−/+) Natural Killer Cell Subsets
por: Ni, Xiang, et al.
Publicado: (2018)

Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea
por: Kong, Doo-Sik, et al.
Publicado: (2016)

Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety
por: Ma, Yue, et al.
Publicado: (2012)

Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer
por: Wang, Zibing, et al.
Publicado: (2016)

An effective cytokine adjuvant vaccine induces autologous T-cell response against colon cancer in an animal model
por: Ju, Huanyu, et al.
Publicado: (2016)

Developmental and Functional Control of Natural Killer Cells by Cytokines
por: Wu, Yang, et al.
Publicado: (2017)

Clinical Effect of Adjuvant Cytokine-Induced Killer Cells Immunotherapy in Patients with Stage II-IVB Nasopharyngeal Carcinoma after Chemoradiotherapy: A propensity score analysis
por: Zhao, Jing-Jing, et al.
Publicado: (2018)

NaHCO(3) enhances the antitumor activities of cytokine-induced killer cells against hepatocellular carcinoma HepG2 cells
por: Yuan, Ya Hong, et al.
Publicado: (2016)

Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection
por: Pan, Qiu-Zhong, et al.
Publicado: (2020)

Comparison of five staging systems in predicting the survival rate of patients with hepatocellular carcinoma undergoing trans-arterial chemoembolization therapy
por: Chen, Zhan-Hong, et al.
Publicado: (2018)

Cytokine-induced killer cell/dendritic cell–cytokine-induced killer cell immunotherapy for the postoperative treatment of gastric cancer: A systematic review and meta-analysis
por: Wang, Xiang, et al.
Publicado: (2018)

Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis
por: Tang, Peijun, et al.
Publicado: (2022)

Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition
por: Wei, Fang, et al.
Publicado: (2015)

One Single Site Clinical Study: To Evaluate the Safety and Efficacy of Immunotherapy With Autologous Dendritic Cells, Cytokine-Induced Killer Cells in Primary Hepatocellular Carcinoma Patients
por: Xu, Kaiyue, et al.
Publicado: (2020)

Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer
por: Shi, Liangrong, et al.
Publicado: (2012)

Natural killer cells inhibit pulmonary metastasis of hepatocellular carcinoma in nude mice
por: HONG, ZAI-FA, et al.
Publicado: (2016)

Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection: Erratum
Publicado: (2016)

Improved Activation toward Primary Colorectal Cancer Cells by Antigen-Specific Targeting Autologous Cytokine-Induced Killer Cells
por: Schlimper, Claudia, et al.
Publicado: (2012)

Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells
por: Kim, Ji Sung, et al.
Publicado: (2015)

The Novel-Natural-Killer-Cell-Related Gene Signature Predicts the Prognosis and Immune Status of Patients with Hepatocellular Carcinoma
por: Li, Minjun, et al.
Publicado: (2023)

MicroRNA-34a-5p enhances sensitivity to chemotherapy by targeting AXL in hepatocellular carcinoma MHCC-97L cells
por: LI, XIAO-YUN, et al.
Publicado: (2015)

Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy
por: Cai, Xiu-Rong, et al.
Publicado: (2018)

Periodontitis Exacerbates and Promotes the Progression of Chronic Kidney Disease Through Oral Flora, Cytokines, and Oxidative Stress
por: Li, Ling, et al.
Publicado: (2021)

Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trials
por: Wang, Yan, et al.
Publicado: (2017)

Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
por: Cao, Jing, et al.
Publicado: (2019)

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis
por: Yuan, Xin, et al.
Publicado: (2021)

Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
por: Omata, Masao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_435jiumim18cmnd5aohhqcmcml